Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
martedì, novembre 17
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Kestra Medical Technologies Ltd
KMTS
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$28.20
0.23
0.82%
Ult. Agg.: Nov 17, 12:06 PM
Get Report
Panoramica
Notizie
Grafici
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Rapporto azionario
Kestra Medical Techs Financials
Kestra Medical Techs (KMTS) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Kestra Medical Techs Q1 EPS $(0.75) Misses $(0.62) Estimate, Sales $30.971M Beat $29.007M Estimate
Kestra Medical Techs (NASDAQ:KMTS) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.62) by 20.97 percent. This is a 50 percent decrease over losses of $(0.50) per share
Benzinga Newsdesk
PRO
Kestra Medical Techs Raises FY2027 Sales Guidance from $137.000M to $141.000M vs $137.023M Est
Kestra Medical Techs (NASDAQ:KMTS) raises FY2027 sales outlook from $137.000 million to $141.000 million vs $137.023 million estimate.
Benzinga Newsdesk
Kestra Likely To Report Q1 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Kestra Medical Technologies will report its first earnings Sept. 14, with analysts expecting a $0.62 EPS loss and $29.01M revenue.
Avi Kapoor
PRO
Kestra Medical Techs Sees FY2027 Sales $137.000M vs $132.895M Est
Kestra Medical Techs (NASDAQ:KMTS) sees FY2027 sales of $137.000 million vs $132.895 million analyst estimate.
Benzinga Newsdesk
PRO
Kestra Medical Techs Q4 EPS $(0.67) Misses $(0.59) Estimate, Sales $28.638M Beat $26.479M Estimate
Kestra Medical Techs (NASDAQ:KMTS) reported quarterly losses of $(0.67) per share which missed the analyst consensus estimate of $(0.59) by 13.56 percent. This is a 69.68 percent increase over losses of $(2.21) per
Benzinga Newsdesk
Earnings Scheduled For July 14, 2026
Companies Reporting Before The Bell • Grupo Aeroportuario del (NYSE:PAC) is likely to report quarterly earnings at $3.25 per share on revenue of $862.92 million. • JPMorgan Chase (NYSE:JPM) is projected to report
Benzinga Insights